SSRI use and risk of fractures among perimenopausal women without mental disorders (Q38991264)

8 September 2017

title

SSRI use and risk of fractures among perimenopausal women without mental disorders (English)

1 reference

8 September 2017

3

Til Stürmer

1 reference

8 September 2017

4

Virginia Pate

1 reference

8 September 2017

5

Deborah Azrael

1 reference

8 September 2017

Yi-han Sheu

1

1 reference

8 September 2017

Amy Lanteigne

series ordinal

2

1 reference

8 September 2017

Matthew Miller

series ordinal

6

1 reference

8 September 2017

publication date

25 June 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

21

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

397-403

1 reference

Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

FDA approval of paroxetine for menopausal hot flushes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Effect of escitalopram on hot flash interference: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Phase III evaluation of fluoxetine for treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Clinical practice. Management of menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Depression and osteoporosis: epidemiology and potential mediating pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

A possible role of recurrent major depression in risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Identification and validation of vertebral compression fractures using administrative claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Marginal Structural Models as a Tool for Standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Use of antidepressant medications and risk of fracture in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Relationship between use of antidepressants and risk of fractures: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Depression, selective serotonin reuptake inhibitors, and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Meta-analysis: risk of fractures with acid-suppressing medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/INJURYPREV-2014-041483

10.1136/INJURYPREV-2014-041483

21 January 2018

Identifiers

DOI

1 reference

release_gc34r545nbckjhdgy2kqw34zgq

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gc34r545nbckjhdgy2kqw34zgq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference